The scientist’s investigation covers issues in Immunology, Transplantation, Hematopoietic stem cell transplantation, Internal medicine and Surgery. His Immunology study incorporates themes from Haematopoiesis, Stem cell and Genetic enhancement, Suicide gene. His study in Transplantation is interdisciplinary in nature, drawing from both Survival rate, Human leukocyte antigen, Immune system and Risk factor.
His work deals with themes such as Myeloid, Cyclophosphamide, Graft-versus-host disease, Transplantation Conditioning and Bone marrow, which intersect with Hematopoietic stem cell transplantation. His research brings together the fields of Oncology and Internal medicine. His Surgery research includes themes of Gastroenterology, Muscle biopsy and Clinical trial.
His primary areas of investigation include Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Oncology. His Internal medicine research integrates issues from Gastroenterology and Surgery. His Transplantation research also works with subjects such as
His Hematopoietic stem cell transplantation research focuses on Fludarabine and how it connects with ThioTEPA and Busulfan. His studies in Immunology integrate themes in fields like Haematopoiesis and Suicide gene. His Oncology study combines topics in areas such as Treosulfan and Minimal residual disease.
Fabio Ciceri focuses on Internal medicine, Transplantation, Coronavirus disease 2019, Oncology and Gastroenterology. His Cyclophosphamide, Acute leukemia, Myeloid leukemia, Incidence and Pneumonia study are his primary interests in Internal medicine. Fabio Ciceri combines subjects such as Human leukocyte antigen and Bone marrow with his study of Cyclophosphamide.
His study in Hematopoietic stem cell transplantation and Graft-versus-host disease falls within the category of Transplantation. Fabio Ciceri studied Coronavirus disease 2019 and 2019-20 coronavirus outbreak that intersect with Betacoronavirus and Immunology. His biological study spans a wide range of topics, including Hematopoietic cell, Prospective cohort study, Leukemia, Post transplant cyclophosphamide and Treosulfan.
The scientist’s investigation covers issues in Internal medicine, Coronavirus disease 2019, Pneumonia, Disease and Transplantation. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology. His research in Pneumonia intersects with topics in Diabetes mellitus, Asymptomatic, ARDS and Immunology.
His research integrates issues of Cell and Efficacy in his study of Immunology. Fabio Ciceri studies Transplantation, focusing on Graft-versus-host disease in particular. The study incorporates disciplines such as Hematopoietic stem cell transplantation, Haematopoiesis, Maintenance therapy and Marrow transplantation in addition to Acute leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede.
The New England Journal of Medicine (2013)
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani.
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
Alessandro Aiuti;Federica Cattaneo;Stefania Galimberti;Ulrike Benninghoff.
The New England Journal of Medicine (2009)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Alessandro Aiuti;Luca Biasco;Samantha Scaramuzza;Francesca Ferrua.
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Giulio Cavalli;Giacomo De Luca;Corrado Campochiaro;Emanuel Della-Torre.
The Lancet Rheumatology (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis.
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli;Barbara Camisa;Giulia Barbiera;Laura Falcone.
Nature Medicine (2018)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi;Pietro Genovese;Angelo Lombardo;Zulma Magnani.
Nature Medicine (2012)
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Renato Bassan;Orietta Spinelli;Elena Oldani;Tamara Intermesoli.
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors
Nicoletta Cieri;Barbara Camisa;Fabienne Cocchiarella;Mattia Forcato.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: